Oxigénio Medicinal Gasoso Sol (Oxygen)

Oxygen, the active ingredient in Oxigénio Medicinal Gasoso Sol, is a medical gas presented as a gas for inhalation use. It provides respiratory support for patients requiring supplemental oxygen therapy, particularly in acute or chronic hypoxic conditions. GNH USA supplies Oxigénio Medicinal Gasoso Sol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

GNH USA supplies Oxigénio Medicinal Gasoso Sol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Oxigénio Medicinal Gasoso Sol is used in respiratory care to improve oxygenation in various clinical situations.

- Acute hypoxemia: restores normal blood oxygen levels during emergencies. - Chronic obstructive pulmonary disease (COPD): reduces breathlessness and improves exercise tolerance. - Post‑operative recovery: supports tissue oxygenation after surgery. - Neonatal care: assists premature infants with under‑developed lungs. - High‑altitude exposure: prevents hypoxic symptoms for individuals at altitude.

Oxygen therapy is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Dry or irritated nasal passages. - Cough or mild throat irritation. - Headache, especially with high flow rates. - Mild fatigue or drowsiness.

Serious or Rare Side Effects: - Pulmonary oxygen toxicity leading to atelectasis. - Retinopathy of prematurity in preterm infants. - Fire hazard if used near open flames. - Worsening of chronic CO₂ retention in COPD patients. - Severe hypoxemia if delivery system fails. - Hypercapnia hyper‑hyper   -   - 

Oxigated ​  

-   a  

   t   t   d   d

t  \